| Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226) |
|---|
| 03/02/2006 | CA2578168A1 2-phenylpyridine derivative |
| 03/02/2006 | CA2578122A1 Pyrimidine derivatives |
| 03/02/2006 | CA2577251A1 Pyrimidine derivatives |
| 03/02/2006 | CA2577191A1 4-heteroarylmethyl substituted phthalazinone derivatives |
| 03/02/2006 | CA2577061A1 Histamine h3 receptor agents, preparation and therapeutic uses |
| 03/02/2006 | CA2575670A1 Aliphatic amide & ester pyrazinoylguanidine sodium channel blockers |
| 03/01/2006 | EP1630159A1 5-HT7 receptor antagonists |
| 03/01/2006 | EP1630158A1 5-HT7 receptor antagonists |
| 03/01/2006 | EP1628970A2 Heterocycle substituted carboxylic acids as inhibitors of protein tyrosine phosphatase-1b |
| 03/01/2006 | EP1628968A1 4-imidazolin-2-one compounds |
| 03/01/2006 | EP1628967A1 Immunosuppressant compounds and compositions |
| 03/01/2006 | EP1628957A1 Sulfopyrroles |
| 03/01/2006 | EP1628685A2 Antiviral phosphonate analogs |
| 03/01/2006 | EP1628661A2 Modulators of vr1 receptor |
| 03/01/2006 | EP1628619A2 4-aminopyrimidine-5-one |
| 03/01/2006 | EP1628532A2 Methods for the protection of memory and cognition |
| 03/01/2006 | EP1278520B1 Diaryl piperidyl pyrrole derivatives as antiprotozoal agents |
| 03/01/2006 | EP1233962B1 Novel heterocyclic compounds and their use as medicines |
| 03/01/2006 | EP1098638B1 Use of a glucose uptake enhancer for reducing post-ischemic injury of the heart |
| 03/01/2006 | EP0842923B1 Pyrrole derivatives and medicinal composition |
| 03/01/2006 | CN1742007A Indole-derivative modulators of steroid hormone nuclear receptors |
| 03/01/2006 | CN1741999A Pyridazinone derivatives as GSK-3beta inhibitors |
| 03/01/2006 | CN1741986A Amide derivatives and their use as inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1 |
| 03/01/2006 | CN1740171A Second order non-linear optical chromophore containing indolyl radical and its prepn and application |
| 03/01/2006 | CN1740151A 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
| 03/01/2006 | CN1740150A 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
| 03/01/2006 | CN1243751C Piperidine compounds as anti-allergic medicine |
| 03/01/2006 | CN1243747C Heteroaromatic carboxamide derivatives and their use as inhibitors of the enzyme IKK-2 |
| 03/01/2006 | CN1243735C 2-lminopyrrolidine derivatives |
| 02/28/2006 | US7005440 Therapeutic uses of tri-aryl acid derivatives |
| 02/28/2006 | US7005439 Compounds |
| 02/28/2006 | US7005436 Heterocyclo inhibitors of potassium channel function |
| 02/28/2006 | US7005435 Lactam-containing compounds and derivatives thereof as factor Xa inhibitors |
| 02/28/2006 | US7005433 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 02/28/2006 | US7005432 Central nervous system disorder; antidepressants; analgesics |
| 02/28/2006 | CA2331877C Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |
| 02/28/2006 | CA2180444C Water soluble onium salt of taxo-diterpenoid |
| 02/23/2006 | WO2006020879A1 Isoindolone compounds and their use as metabotropic glutamate receptor potentiators |
| 02/23/2006 | WO2006020156A2 Heterocyclic dye compounds for in vivo imaging and diagnosis of alzheimer’s disease |
| 02/23/2006 | WO2006019957A2 Heterocyclyls as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders |
| 02/23/2006 | WO2006019497A2 Sleep-inducing compounds and methods related thereto |
| 02/23/2006 | WO2006018973A1 Oxime ester compound and photopolymerization initiator containing such compound |
| 02/23/2006 | WO2006018855A1 Novel antidiabetic compounds |
| 02/23/2006 | WO2006018544A1 Composition containing a thiophenic or benzothiophenic compound and exhibiting a pump nora inhibiting activity |
| 02/23/2006 | WO2006018443A1 Heterocyclic condensed compounds useful as antidiuretic agents |
| 02/23/2006 | WO2006018309A1 5-ht7 receptor antagonists |
| 02/23/2006 | WO2006018308A1 5-ht7 receptor antagonists |
| 02/23/2006 | WO2006018284A1 Compounds and compositions useful as cathepsin s inhibitors |
| 02/23/2006 | WO2006018184A2 Spirocyclic cyclohexane derivatives |
| 02/23/2006 | WO2006017921A1 Selective muscle relaxant and pharmaceutical compositions |
| 02/23/2006 | WO2005115145A3 Quinone substituted quinazoline and quinoline kinase inhibitors |
| 02/23/2006 | US20060041142 demetallization to prepare of 2,4'-bipyridine, 4-methyl-2-(2'-pyridyl)pyridine, 2,3'-bipyridine, 6-chloro-2-(2'-thienyl)pyridine, or 2-(3'-thienyl)pyridine; synthetic intermediate for fungicides |
| 02/23/2006 | US20060041139 Antagonists for melanin concentrating hormone-1 receptors; antidepressants, anxiolytic agents; incontinence, obesity |
| 02/23/2006 | US20060041006 PDE4B inhibitors and uses therefor |
| 02/23/2006 | US20060040995 Method for preparing hydroxypicolinic scid derivatives |
| 02/23/2006 | US20060040967 6-Fluoroalkyl-4-(5-sulfonyl-2-pyridyl)-substituted, e.g., 4-(5-Methanesulfonyl-pyridin-2-yl)-6-trifluoromethyl-pyrimidin-2-yl]-methyl-(6-methyl-pyridin-2-ylmethyl)-amine; treating pain, fever and inflammation without the potential side effects of other COX inhibitors |
| 02/23/2006 | US20060040956 Substituted alkylamine derivatives and methods of use |
| 02/23/2006 | US20060040950 Substituted 1-piperidin-4-yl-4-pyrrolidin-3-yl-piperazine derivatives and their use as neurokinin antagonists |
| 02/23/2006 | US20060040923 1,1-Diethyl-3-(2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-urea; respiratory syncytial virus; cost efficient replacement for Synagis (palivizumab) used for RSV; respiratory system disorders; asthna; viral diseases; myxoviruses; mumps; flaviviruses; dengue, West Nile, parainfluenza viruses |
| 02/23/2006 | US20060040918 Benzo d!azepine derivatives for the treatment of neurological disorders |
| 02/23/2006 | CA2581327A1 Intracellular receptor modulator compounds and methods |
| 02/23/2006 | CA2577668A1 Novel antidiabetic compounds |
| 02/23/2006 | CA2575853A1 Isoindolone compounds and their use as metabotropic glutamate receptor potentiators |
| 02/23/2006 | CA2575826A1 Compounds and compositions useful as cathepsin s inhibitors |
| 02/23/2006 | CA2575785A1 5-ht7 receptor antagonists |
| 02/23/2006 | CA2575771A1 5-ht7 receptor antagonists |
| 02/23/2006 | CA2573819A1 Heterocyclic dye compounds for in vivo imaging and diagnosis of alzheimer's disease |
| 02/23/2006 | CA2573772A1 Heterocyclyls as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders |
| 02/23/2006 | CA2573764A1 Hydantoin derivatives for the treatment of inflammatory disorders |
| 02/23/2006 | CA2573730A1 1,2,3,4-tetrahydropyrazin-2-yl acetamides and their use as bradykinin antagonists for the treatment of inflammation related disorders |
| 02/23/2006 | CA2567782A1 Heterocyclic condensed compounds useful as antidiuretic agents |
| 02/22/2006 | EP1627876A1 Heterocyclic condensed compounds useful as antidiuretic agents |
| 02/22/2006 | EP1626967A1 Substituted pyrazoles |
| 02/22/2006 | EP1626966A1 Benzofuran inhibitors of factor viia |
| 02/22/2006 | EP1626961A1 Novel 2-oxo-heterocyclic compounds and the pharmaceutical compositions comprising the same |
| 02/22/2006 | EP1626960A1 Diarylmethylidene piperidine derivatives and their use as delta opioid receptor agonists |
| 02/22/2006 | EP1626958A1 (piperidinyloxy)phenyl, (piperidinyloxy)pyridinyl, (piperidinylsulfanyl)phenyl and (piperidinylsulfanyl)pyridinyl compounds as 5-ht 1f agonists |
| 02/22/2006 | EP1406622B1 Dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 02/22/2006 | EP1385839B1 3-substituted quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists |
| 02/22/2006 | EP1237874B1 Selective neurokinin antagonists |
| 02/22/2006 | EP1121431B1 Non-endogenous, constitutively activated human g protein-coupled receptors |
| 02/22/2006 | EP1105375B1 Trifluoromethylpyrrolcarboxamides useful as fungicides |
| 02/22/2006 | CN1738814A Indolyl pyrazinone derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis |
| 02/22/2006 | CN1738812A Thiophene carboxamides as inhibitors of the enzyme IKK-2 |
| 02/22/2006 | CN1738807A Substituted aralkyl derivatives |
| 02/22/2006 | CN1738804A 吡唑化合物 Pyrazole compounds |
| 02/22/2006 | CN1738801A Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof |
| 02/22/2006 | CN1738797A Substituted aryl thioureas and related compounds; inhibitors of viral replication |
| 02/22/2006 | CN1738618A Pharmaceutical compositions and their uses |
| 02/22/2006 | CN1242995C Novel compounds, their use and preparation |
| 02/22/2006 | CN1242991C Aporphine esters and their use in therapy |
| 02/21/2006 | US7002022 treatment of neoplastic diseases that respond to inhibition of the vascular endothelial growth factor receptor tyrosine kinase activity; tumors, retinopathy, macular degeneration |
| 02/21/2006 | US7001907 Peptide-containing α-ketoamide cysteine and serine protease inhibitors |
| 02/21/2006 | US7001904 Guanidine derivatives quinazoline and quinoline for use in the treatment of autoimmune diseases |
| 02/21/2006 | US7001899 7-member ring N-heterocycles that have a cysteine trap substitution; treating osteoarthritis |
| 02/21/2006 | US7001895 Pyridazinones; selective inhibitors of the induced isozyme PGHS-2 (Title) and cyclooxygenase 2 (COX-2); side effect reduction; analgesics; antipyretics; antiinflamation, -arthritic and -carcinogenic agents; rheumatic diseases; |
| 02/21/2006 | CA2283399C Pyridazinones as inhibitors of cyclooxygenase-2 |
| 02/21/2006 | CA2250347C Piperazine and piperidine compounds with high affinity for dopamine-d2 and serotonin-5ht1a receptors |
| 02/16/2006 | WO2006015860A2 Pyrazole derivatives for treating conditions mediated by activation of the adenosine a2b or a3 receptor |
| 02/16/2006 | WO2006015851A1 Piperazine derivatives with ccr3 inhibiting activity |